Debt to EBITDA ratio Analysis of Vaccinex Inc - Deep Dive
Debt to EBITDA of VCNX
Dec-23-0.0113Very Poor Debt to EBITDA | Dec-22-0.0172Very Poor Debt to EBITDA | Growth34.38% |
Debt to EBITDA Analysis of Vaccinex Inc
Debt to EBITDA Ratio of VCNX rose handsomely by 34.38 % this year. |
Debt to EBITDA Ratio of VCNX trending up for at least three Years. |
Debt to EBITDA Ratio with value of -0.328 was lowest in Year Dec-20 in last Five Years. |
Latest Debt to EBITDA Ratio with value of -0.0113 is Greater than Average Debt to EBITDA of -0.075 in last five years. |
Other Debt to EBITDA Related Info of VCNX that may interest you.
Vaccinex Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
VCNX | 6.51 | 6.855 | 5.03 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..Debt to EBITDA Related Ratios
CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
Poor Stability Stock |
FY - Historical Debt to EBITDA of Vaccinex Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Debt to EBITDA | -0.0113 | -0.0172 | -0.0182 | -0.328 | 0 | 0 | -0.328 |
Change | 34.38 % | 5.56 % | 94.45 % | 0 % | -70.35 % |
FY Chart of Debt to EBITDA of Vaccinex Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)